期刊
TRANSCRIPTION-AUSTIN
卷 4, 期 4, 页码 146-152出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/trns.25146
关键词
cyclin-dependent kinase; transcription; RNA polymerase II; TFIIH; positive transcription elongation factor b; promoter-proximal pausing; termination; chemical genetics; RNA-processing
资金
- National Institutes of Health [GM056985, GM076021]
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056985, R01GM076021] Funding Source: NIH RePORTER
Cyclin-dependent kinases (CDKs) play a central role in governing eukaryotic cell division. It is becoming clear that the transcription cycle of RNA polymerase II (RNAP II) is also regulated by CDKs; in metazoans, the cell cycle and transcriptional CDK networks even share an upstream activating kinase, which is itself a CDK. From recent chemical-genetic analyses we know that CDKs and their substrates control events both early in transcription (the transition from initiation to elongation) and late (3' end formation and transcription termination). Moreover, mutual dependence on CDK activity might couple the beginning and end of the cycle, to ensure the fidelity of mRNA maturation and the efficient recycling of RNAP II from sites of termination to the transcription start site (TSS). As is the case for CDKs involved in cell cycle regulation, different transcriptional CDKs act in defined sequence on multiple substrates. These phosphorylations are likely to influence gene expression by several mechanisms, including direct, allosteric effects on the transcription machinery, co-transcriptional recruitment of proteins needed for mRNA-capping, splicing and 3' end maturation, dependent on multisite phosphorylation of the RNAP II C-terminal domain (CTD) and, perhaps, direct regulation of RNA-processing or histone-modifying machinery. Here we review these recent advances, and preview the emerging challenges for transcription-cycle research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据